- Home
- GH vs SKYW Comparison
GH vs SKYW Comparison
Compare GH & SKYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- SKYW
- Stock Information
- Founded
- GH 2011
- SKYW 1972
- Country
- GH United States
- SKYW United States
- Employees
- GH N/A
- SKYW N/A
- Industry
- GH Medical Specialities
- SKYW Air Freight/Delivery Services
- Sector
- GH Health Care
- SKYW Consumer Discretionary
- Exchange
- GH Nasdaq
- SKYW Nasdaq
- Market Cap
- GH 4.9B
- SKYW 4.6B
- IPO Year
- GH 2018
- SKYW N/A
- Fundamental
- Price
- GH $61.40
- SKYW $119.08
- Analyst Decision
- GH Strong Buy
- SKYW Strong Buy
- Analyst Count
- GH 16
- SKYW 4
- Target Price
- GH $57.50
- SKYW $126.75
- AVG Volume (30 Days)
- GH 3.4M
- SKYW 322.1K
- Earning Date
- GH 07-30-2025
- SKYW 07-24-2025
- Dividend Yield
- GH N/A
- SKYW N/A
- EPS Growth
- GH N/A
- SKYW 132.99
- EPS
- GH N/A
- SKYW 9.81
- Revenue
- GH $828,849,000.00
- SKYW $3,840,870,000.00
- Revenue This Year
- GH $23.36
- SKYW $14.40
- Revenue Next Year
- GH $21.43
- SKYW $4.63
- P/E Ratio
- GH N/A
- SKYW $12.14
- Revenue Growth
- GH 28.74
- SKYW 20.45
- 52 Week Low
- GH $20.14
- SKYW $72.70
- 52 Week High
- GH $62.81
- SKYW $135.57
- Technical
- Relative Strength Index (RSI)
- GH 72.00
- SKYW 61.05
- Support Level
- GH $57.41
- SKYW $112.20
- Resistance Level
- GH $59.92
- SKYW $118.51
- Average True Range (ATR)
- GH 2.54
- SKYW 3.28
- MACD
- GH 0.99
- SKYW 0.00
- Stochastic Oscillator
- GH 92.69
- SKYW 92.86
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About SKYW SkyWest Inc.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers's brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines, which generates maximum revenue, and SkyWest Leasing.